プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Adam E.に依頼

Australia

Freelance drug and medical device Regulatory Affairs consultant | Expert in preclinical and clinical trial design

プロフィール概要

My research interests are in the design, development and assessment of novel drugs to prevent brain injury in infants and adults.

専門分野

• ☆ Neurochemistry
• ☆ Drug Development
• ☆ Pharmaceutical Regulatory Affairs
• ☆ Medical Devices
• ☆ Medical Device Regulatory Consulting
• ☆ Medicine
• ☆ Clinical Trials
• ☆ Clinical Trial Design
• ☆ Regulatory Affairs
• ☆ Regulatory Writing
• ☆ Medical Device Regulatory Writing

サービス

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Medical Writing, Non-Medical Regulatory Writing, Technical Writing

Research Gap Analysis, Scientific and Technical Research, Systematic Literature Review

Consulting Scientific and Technical Consulting, Regulatory Consulting

Data & AI Statistical Analysis, Image Processing, Image Analysis

Product Development Formulation, Stability/Shelf Life Testing, Product Validation, Quality Assurance & Control (QA/QC)

職務経験

Research Officer

Sir Charles Gairdner Hospital

7月 2018 - 現在

Research Officer

Perron Institute for Neurological and Translational Science

7月 2018 - 現在

学歴

Doctorate of Philosophy (PhD) (Health Sciences)

University of Notre Dame Australia

1月 2015 - 8月 2018

Bachelor of Biomedical Science (Hons) (Health Sciences)

University of Notre Dame Australia

3月 2011 - 12月 2014

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2018). Assessment of therapeutic window for poly-arginine-18D (R18D) in a P7 rat model of perinatal hypoxic-ischaemic encephalopathy . Journal of Neuroscience Research. 96. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1816-1826.

Edwards, A.B., Cross, J.L., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2018). Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat . Molecular Brain. 11. (1).

Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2018). Perinatal hypoxic-ischemic encephalopathy and neuroprotective peptide therapies: A case for cationic arginine-rich peptides (CARPs) . Brain Sciences. 8. (8).

Chiu, L.S., Anderton, R.S., Cross, J.L., Clark, V.W., Chiu, L.S., Anderton, R.S., Cross, J.L., Clark, V.W., Edwards, A.B., Knuckey, N.W., et al.(2017). Assessment of R18, COG1410, and APP96-110 in excitotoxicity and traumatic brain injury . Translational Neuroscience. 8. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 147-157.

Meloni, B.P., Milani, D., Cross, J.L., Meloni, B.P., Milani, D., Cross, J.L., Clark, V.W., Edwards, A.B., Anderton, R.S., Blacker, D.J., et al.(2017). Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine–Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats . NeuroMolecular Medicine. 19. (2-3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 271-285.

Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P., Edwards, A.B., Anderton, R.S., Knuckey, N.W., Meloni, B.P.(2017). Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model . Molecular and Cellular Biochemistry. 426. (1-2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 75-85.

Edwards, A.B., Feindel, K.W., Cross, J.L., Anderton, R.S., Clark, V.W., Knuckey, N.W., Meloni, B.P.(2017). Modification to the Rice-Vannucci perinatal hypoxic-ischaemic encephalopathy model in the P7 rat improves the reliability of cerebral infarct development after 48 hours . Journal of Neuroscience Methods. 288. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 62-71.

Meloni, B.P., Brookes, L.M., Clark, V.W., Cross, J.L., Edwards, A.B., Anderton, R.S., Hopkins, R.M., Hoffmann, K., Knuckey, N.W.(2015). Poly-arginine and arginine-rich peptides are neuroprotective in stroke models . Journal of Cerebral Blood Flow and Metabolism. 35. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 993-1004.

(2015). Neuroprotective peptides fused to arginine-rich cell penetrating peptides: Neuroprotective mechanism likely mediated by peptide endocytic properties . Pharmacology and Therapeutics. 153. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 36-54.